Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hemophilia
Pharma
Sanofi unit in Ireland dinged by FDA on Altuviiio production
After a site visit by FDA inspectors yielded a Form 483 for Genzyme in early 2026, the Sanofi unit is facing further scrutiny from the regulator.
Fraiser Kansteiner
Jul 1, 2026 2:52pm
FDA signs off on pediatric use of Pfizer's hemophilia treatment
Jun 8, 2026 10:32am
Genentech shifts Hemlibra marketing focus to patient stories
Apr 20, 2026 9:30am
Sanofi backs 2 more films about rare blood disorders
Mar 20, 2026 1:04pm
CSL's Hemgenix in 'temporary global stockout,' company says
Mar 19, 2026 4:35pm
BioMarin pulls gene therapy Roctavian off the market
Feb 24, 2026 12:30pm
